Share on StockTwits

BioMed Realty Trust (NYSE:BMR) is scheduled to release its Q413 earnings data on Thursday, February 6th. Analysts expect BioMed Realty Trust to post earnings of $0.33 per share and revenue of $157.51 million for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

Shares of BioMed Realty Trust (NYSE:BMR) opened at 19.38 on Wednesday. BioMed Realty Trust has a 52-week low of $17.90 and a 52-week high of $23.13. The stock has a 50-day moving average of $18.60 and a 200-day moving average of $19.06. The company has a market cap of $3.695 billion and a P/E ratio of 112.47.

On the ratings front, analysts at KeyCorp downgraded shares of BioMed Realty Trust from a “buy” rating to a “hold” rating in a research note to investors on Thursday, December 19th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $22.60.

BioMed Realty Trust, Inc operates as a real estate investment trust (NYSE:BMR), and the general partner of BioMed Realty, L.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.